R&D of Anti-COVID-19 Drugs is Blooming in China

武汉病毒研究所), has been granted the approval for clinical trials by NMPA for close contacts to COVID-19 positive people as a preventative treatment.SIM0417 targets 3CL protease for inhibiting the replication of coronavirus and is undergoing clinical trial for COVID-19 cases. According to the ...

Huawei’s W. Genovese on COVID-19 and 5G

In this chapter, we touch upon COVID-19 and 5G. Check out the rest of the interview:  5G, Its Value and Potential The User’s Perspective, Fintech and 5G 5G and Fintech Huawei and 5G The impact “The impact of COVID-19 on 5G is a very complex question, and it gets more ...

China's First Oral COVID-19 Antiviral Medicine in Dispute

s first domestically produced oral antiviral medications for COVID-19. The three most promising candidates were VV116 of Junshi Biosciences(Chinese: 君实生物), Azivudine of Genuine Biotech and Proxalutamide of Kintor Pharmaceuticals(Chinese: 开拓药业). When the news came on July 25, it was revealed ...

Fosun Pharma’s COVID-19 Vaccine Starts Clinical Phase, Approved by Chinese NMPA

s COVID-19 preventive vaccine has been approved by the National Medical Products Administration to enter clinical trials. If the vaccine passes Phase III, it can officially go to the market into a commercial-stage. Considering the large-scale impact brought by the pandemic, there is a considerable ...

Meituan Maiyao Releases Covid-19 Antigen Self-testing Kits

Meituan Maiyao (Chinese: 美团买药), an online medical service provider under Chinese delivery giant Meituan (3690: HK), was the first platform in China to open pre-sale for home-use Covid-19 test products on March 13.China’s National Medical Products Administration approved the sale of five ...

China Speed: Two COVID-19 Vaccines Recognized by WHO

has two COVID-19 candidate vaccines to be approved by NMPA. It may first catch the enormous vaccine market opportunity. ► COVID-19 vaccine makers worldwide have conducted different research and are speeding up their clinical trials. ► Among all the vaccine developers for the ten in the clinical ...

Blockchain and Covid-19 | Key Takeaways from Webinar ‘Blockchain, China’s Story’

Blockchain and COVID-19 Blockchain in 2020 How can we leverage the blockchain technology to meet the current challenges brought by the pandemic? Antonio: I think one important aspect of the adoption of blockchain technology addresses the COVID-19 is to manage contact tracing. In tracing...

EqualOcean on Lufax: Unexpected Stimulus of COVID-19 (2/8)

The COVID-19 pandemic came unexpected and hit the entire financial services industry hard, especially for banks, which mainly serves customers through offline branches. The quarantine caused many traditional FIs to close for a while and deteriorated their asset qualities. By end of September of 2020...

Covid-19 Vaccine Developer CanSino Bio to Trade on Star Market

the Covid-19 Science and Technology Major Project initiated by the Tianjin Science and Technology Commission at the peak of the continued spread of coronavirus. The expected refinancing from China's stock market would help facilitate the development of the Covid-19 vaccine and the optimization ...

Will GSX Shares Rally With the Re-emergence of COVID-19?

Re-emergence of COVID-19 to boost investors' trust in online education companies.GSX Techedu imitated the double-teacher model, which TAL (Xueersi) and New Oriental applied into their teaching methods a long time ago.The amount of losses in 3Q 2020 far exceeded all accumulated ...

Zhifei Completed Phase 3 Trial of A Novel COVID-19 Vaccine

A novel vaccine against COVID-19, ZF2001 (Zifivax), from the China-based developer, Zhifei, that builds its protein subunit platform with a receptor-binding domain (RBD)-dimer demonstrated safety and efficacy in a phase 3 trial. Lead author Lianpan Dai, PhD, CAS Key Laboratory of Pathogen ...

CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist

s first inhaled Covid-19 vaccine mist. The needle-free vaccines that could be highly appealing to vaccine-hesitant people can also be self-administered. The announcement pushed the company’s shares up as much as 14.5 percent Monday morning in Hong KongThe vaccine mist is named Convidecia Air. The ...

Package Locker Operator Hive-Box Waives Storage Fees in Hangzhou over Covid-19

China’s e-locker operator Hive-Box, a subsidiary of logistics giant SF Express, has decided to temporarily waive storage fees for users who fail to pick up their parcels in time due to disruptions by the Covid-19 pandemic.The company made the statement after seven of its staff who worked at a ...

China Eastern Airlines Facing Risks Beyond COVID-19

Due to the natural reduction of traffic and control measures during the COVID-19 pandemic, more than 60% of aircraft have been grounded worldwide. With successful epidemic control, China's aviation market is looking forward to perhaps the quickest recovery in the world. According to the Civil ...

UISEE: Transformation of Autonomous Driving Company after the COVID-19 Crisis

Autonomous logistics and delivery, taking the place of RoboTaxis, have become the new focus of the capital market after the COVID-19 pandemic. Core technology UISEE is a startup that develops autonomous driving solutions for automobile manufacturers. It has focused on Level 4 (L4) autonomous ...